{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:57Z","timestamp":1791489597500,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bpg.2010.07.007","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T12:40:39Z","timestamp":1298032839000},"page":"555-571","source":"Crossref","is-referenced-by-count":151,"title":["Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)"],"prefix":"10.1016","volume":"24","author":[{"given":"Christian P.","family":"Strassburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.07.007_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(00)80411-0","article-title":"Hepatobiliary transport","volume":"32","author":"Kullak-Ublick","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.007_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-195409000-00001","article-title":"Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinical entity with 12 cases","volume":"33","author":"Dubin","year":"1954","journal-title":"Medicine"},{"key":"10.1016\/j.bpg.2010.07.007_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.7326\/0003-4819-41-5-952","article-title":"Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases","volume":"41","author":"Sprintz","year":"1954","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.bpg.2010.07.007_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.bpg.2010.07.007_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bpg.2010.07.007_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1478-3231.2007.01446.x","article-title":"Rotor-type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump","volume":"27","author":"Hrebicek","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2010.07.007_bib7","doi-asserted-by":"crossref","first-page":"G165","DOI":"10.1152\/ajpgi.00362.2002","article-title":"A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)","volume":"284","author":"Keitel","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bpg.2010.07.007_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02389522","article-title":"Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect","volume":"31","author":"Nambu","year":"1996","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.007_bib9","first-page":"91","article-title":"A new diagnostic approach to the Dubin-Johnson syndrome","volume":"85","author":"Pinos","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.007_bib10","article-title":"Familial nonhemolytic jaundice with direct van den Bergh reaction","volume":"5","author":"Rotor","year":"1948","journal-title":"Acta Med Phil"},{"key":"10.1016\/j.bpg.2010.07.007_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/gut.19.6.474","article-title":"New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias","volume":"19","author":"Berthelot","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.007_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000197719","article-title":"Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias","volume":"13","author":"Abe","year":"1975","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2010.07.007_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03602530903209429","article-title":"Gilbert-Meulengracht\u2019s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?","volume":"42","author":"Strassburg","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bpg.2010.07.007_bib14","first-page":"241","article-title":"La cholamae simple familiale","volume":"21","author":"Gilbert","year":"1901","journal-title":"Sem Med"},{"key":"10.1016\/j.bpg.2010.07.007_bib15","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI104682","article-title":"Chronic unconjugated hyperbilirubinemia without signs of overt hemolysis in adolescents and adults","volume":"41","author":"Arias","year":"1962","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.07.007_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0168-8278(00)80285-8","article-title":"Jaundice, genes and promoters","volume":"33","author":"Strassburg","year":"2000","journal-title":"J Hepatology"},{"key":"10.1016\/j.bpg.2010.07.007_bib17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-9258(17)35280-8","article-title":"Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells","volume":"266","author":"Ritter","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI115829","article-title":"Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient","volume":"90","author":"Ritter","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.07.007_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.007_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0016-5085(19)33296-2","article-title":"Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert\u2019s syndrome)","volume":"63","author":"Berk","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.007_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0016-5085(76)80151-5","article-title":"Abnormal hepatic transport of indocyanine green in Gilbert\u2019s syndrome","volume":"70","author":"Martin","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.007_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/gut.17.8.581","article-title":"Alteration of drug metabolism in Gilbert\u2019s syndrome","volume":"17","author":"Carulli","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.007_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-197904030-00004","article-title":"Gilbert\u2019s syndrome and drug metabolism","volume":"4","author":"Macklon","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bpg.2010.07.007_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cbi.2004.08.008","article-title":"Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia","volume":"150","author":"Campbell","year":"2004","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bpg.2010.07.007_bib25","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/hmg\/ddp202","article-title":"Genome-wide association meta-analysis for total serum bilirubin levels","volume":"18","author":"Johnson","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bpg.2010.07.007_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10408360802374624","article-title":"Variability and function of family 1 uridine-5\u2032-diphosphate glucuronosyltransferases (UGT1A)","volume":"45","author":"Strassburg","year":"2008","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.bpg.2010.07.007_bib27","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1074\/jbc.M709244200","article-title":"Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease","volume":"283","author":"Nguyen","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0016-5085(93)90029-C","article-title":"A mutation in bilirubin uridine 5\u2032-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II","volume":"105","author":"Bosma","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.007_bib29","doi-asserted-by":"crossref","first-page":"23573","DOI":"10.1016\/S0021-9258(19)49501-X","article-title":"A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase","volume":"268","author":"Ritter","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bpg.2010.07.007_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1055-9965.EPI-03-0070","volume":"13","author":"Fang","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2010.07.007_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00008571-200212000-00006","article-title":"Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups","volume":"12","author":"Innocenti","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bpg.2010.07.007_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0008-6363(98)00278-8","article-title":"Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?","volume":"41","author":"Siow","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molmed.2005.04.008","article-title":"Bilirubin and the risk of common non-hepatic diseases","volume":"11","author":"Rigato","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bpg.2010.07.007_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1373\/clinchem.2007.102046","article-title":"Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study","volume":"54","author":"Rantner","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib36","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1\u221728 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bpg.2010.07.007_bib37","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.90889.2008","article-title":"Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates angiotensin-II dependent hypertension in mice","author":"Vera","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bpg.2010.07.007_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2009.02.039","article-title":"Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels \u2013 The Framingham Heart Study","author":"Lin","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bpg.2010.07.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.01.001","article-title":"Gilbert syndrome, UGT1A1\u221728 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin","volume":"198","author":"Schwertner","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bpg.2010.07.007_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2133\/dmpk.24.226","article-title":"Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity","volume":"24","author":"Katoh","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bpg.2010.07.007_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3945\/jn.108.097279","article-title":"Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1\u221728 polymorphism","volume":"139","author":"Saracino","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.bpg.2010.07.007_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/mol.104.002832","article-title":"Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties","volume":"66","author":"Kapitulnik","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib43","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1373\/clinchem.2006.078667","article-title":"Further evidence that the UGT1A1\u221728 allele is not associated with coronary heart disease: The ECTIM Study","volume":"52","author":"Gajdos","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/0008-5472.CAN-03-3295","article-title":"The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk","volume":"64","author":"Duguay","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FPC.0b013e328323f66c","article-title":"Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk","volume":"19","author":"McGrath","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.bpg.2010.07.007_bib46","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1182\/blood-2008-03-148874","article-title":"Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis","volume":"113","author":"Ribrag","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2010.07.007_bib47","first-page":"52","article-title":"Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7","volume":"45","author":"Cheng","year":"1998","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bpg.2010.07.007_bib48","first-page":"1978","article-title":"Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes","volume":"62","author":"Fang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib49","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1074\/jbc.M109.075770","article-title":"Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10","volume":"285","author":"Kalthoff","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.07.007_bib50","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.3748\/wjg.v11.i21.3250","article-title":"Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes","volume":"11","author":"Tang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.007_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/gut.50.6.851","article-title":"Polymorphisms of the UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.007_bib52","first-page":"950","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans","volume":"60","author":"Guillemette","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib53","first-page":"711","article-title":"Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels","volume":"10","author":"Guillemette","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2010.07.007_bib54","doi-asserted-by":"crossref","first-page":"R488","DOI":"10.1186\/bcr818","article-title":"UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients","volume":"6","author":"Sparks","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/B:BREA.0000025419.26423.b8","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer","volume":"85","author":"Adegoke","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpg.2010.07.007_bib56","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.21105","article-title":"Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis","volume":"43","author":"Wasmuth","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.007_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2007.06643.x","article-title":"The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease","volume":"138","author":"Vasavda","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpg.2010.07.007_bib58","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V94.7.2259.419k42_2259_2262","article-title":"Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis","volume":"94","author":"del Giudice","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2010.07.007_bib59","doi-asserted-by":"crossref","DOI":"10.1124\/mol.105.015891","article-title":"Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UGT1A enzymes expressed in the breast tissue","author":"Chouinard","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)13456-1","article-title":"Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol","volume":"43","author":"Ebner","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.32.3.314","article-title":"Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia)","volume":"32","author":"Ghosal","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib62","first-page":"251","article-title":"Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds","volume":"25","author":"King","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib63","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/dmd.104.002527","article-title":"Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes","volume":"33","author":"Kuehl","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/dmd.105.007633","article-title":"Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of cyp2c8: implications for drug\u2013drug interactions","volume":"34","author":"Ogilvie","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/dmd.30.5.505","article-title":"Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization","volume":"30","author":"Prueksaritanont","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1665-2681(19)31774-0","article-title":"Gilbert\u2019s syndrome and antiviral therapy of hepatitis C","volume":"8","author":"Deterding","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.bpg.2010.07.007_bib67","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1200\/JCO.2005.05.2464","article-title":"Irinogenetics: what is the right star?","volume":"24","author":"Innocenti","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib68","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1124\/mol.104.007146","article-title":"Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene","volume":"67","author":"Lankisch","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib69","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1008438109725","article-title":"UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan","volume":"9","author":"Ando","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib70","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/mol.62.3.446","article-title":"Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity","volume":"62","author":"Tukey","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib72","first-page":"52","article-title":"Irinotecan treatment in cancer patients with UGT1A1 polymorphisms","volume":"17","author":"Innocenti","year":"2003","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.bpg.2010.07.007_bib73","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.07.007_bib74","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/mol.62.3.608","article-title":"Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)","volume":"62","author":"Gagne","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bpg.2010.07.007_bib75","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib76","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes","volume":"101","author":"Iyer","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.07.007_bib77","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6602042","article-title":"UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer","volume":"91","author":"Marcuello","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpg.2010.07.007_bib78","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1158\/1078-0432.CCR-03-0548","article-title":"Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients","volume":"10","author":"Rouits","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib79","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/1078-0432.1226.11.3","article-title":"UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine\/irinotecan","volume":"11","author":"Carlini","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2010.07.007_bib80","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2006.10.2301","article-title":"UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan","volume":"25","author":"Stewart","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10147-008-0821-z","article-title":"UGT1A1\u22176 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients","volume":"14","author":"Onoue","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/bbrc.1999.0453","article-title":"Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus","volume":"260","author":"Ciotti","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpg.2010.07.007_bib83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008571-200010000-00006","article-title":"Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene","volume":"10","author":"Guillemette","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bpg.2010.07.007_bib84","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.106.110924","article-title":"The contribution of intestinal Udp-glucuronosyltrasferases in modulating Sn-38 induced gastrointestinal toxicity in rats","author":"Tallman","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bpg.2010.07.007_bib85","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1055-9965.EPI-07-2517","article-title":"Gilbert\u2019s syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk","volume":"17","author":"Lankisch","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2010.07.007_bib86","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2008.19.0314","article-title":"Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan","volume":"27","author":"Cecchin","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpg.2010.07.007_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2353\/jmoldx.2008.080036","article-title":"Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert\u2019s syndrome marker UGT1A1\u221728","volume":"10","author":"Ehmer","year":"2008","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.bpg.2010.07.007_bib88","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.06.048","article-title":"Coffee induces expression of glucuronosyltransferases via the aryl hydrocarbon receptor and Nrf2 in liver and stomach","author":"Kalthoff","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.007_bib89","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/466531","article-title":"Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia","volume":"192","author":"Rotger","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2010.07.007_bib90","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1073\/pnas.231140698","article-title":"Mechanism of indinavir-induced hyperbilirubinemia","volume":"98","author":"Zucker","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpg.2010.07.007_bib91","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpg.2010.07.007_bib92","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.21361","article-title":"Gilbert\u2019s disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype","volume":"44","author":"Lankisch","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.007_bib93","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2008.12.030","article-title":"Gilbert\u2019s syndrome and hyperbilirubinemia in protease inhibitor therapy \u2013 an extended haplotype of genetic variants increases risk in indinavir treatment","volume":"50","author":"Lankisch","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.007_bib94","first-page":"129","article-title":"Caffeine clearance in subjects with constitutional unconjugated hyperbilirubinemia","volume":"27","author":"Testa","year":"1995","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.007_bib95","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood-2004-02-0521","article-title":"UGT1A1 variation and gallstone formation in sickle cell disease","volume":"105","author":"Haverfield","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2010.07.007_bib96","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert\u2019s syndrome","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.07.007_bib97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/abbi.1996.0320","article-title":"The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1","volume":"332","author":"King","year":"1996","journal-title":"Arch Biochem Biophys"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T14:54:53Z","timestamp":1740927293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1521691810000867"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.07.007","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}